Skip to main content
. 2018 May 8;23:300–309. doi: 10.12659/AOT.907666

Figure 1.

Figure 1

The association between body weight and Tac C0 on day 7 after transplantation among patients with different CYP3A5 genotypes. (A) Patients who received 2 mg/day as Tac starting dose. (B) Patients who received 3 mg/day as Tac starting dose. Shaded part is the target Tac C0 range (5–8 ng/ml).